McAlister VC - Search Results

1

Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation.

McAlister CC, Gao ZH, McAlister VC, Gupta R, Wright JR Jr, MacDonald AS, Peltekian K. McAlister CC, et al. Among authors: mcalister vc. Liver Transpl. 2004 Feb;10(2):315-9. doi: 10.1002/lt.20062. Liver Transpl. 2004. PMID: 14762873 Free article.

2

Immunoglobulin-G subclass antidonor reactivity in transplant recipients.

Gao ZH, McAlister VC, Wright JR Jr, McAlister CC, Peltekian K, MacDonald AS. Gao ZH, et al. Among authors: mcalister vc, mcalister cc. Liver Transpl. 2004 Aug;10(8):1055-9. doi: 10.1002/lt.20154. Liver Transpl. 2004. PMID: 15390333 Free article.

3

Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.

Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, Nashan B, Peltekian KM. Laryea M, et al. Among authors: mcalister vc. Liver Transpl. 2007 Aug;13(8):1109-14. doi: 10.1002/lt.21126. Liver Transpl. 2007. PMID: 17663411 Free article.

4

Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.

Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K. Greig P, et al. Liver Transpl. 2003 Jun;9(6):587-95. doi: 10.1053/jlts.2003.50102. Liver Transpl. 2003. PMID: 12783400 Free article. Clinical Trial.

5

Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model.

Yang H, McAlister VC, Al-Jazaeri A, Wright JR Jr. Yang H, et al. Among authors: mcalister vc. Transplantation. 2002 Mar 15;73(5):710-3. doi: 10.1097/00007890-200203150-00009. Transplantation. 2002. PMID: 11907415

6

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.

McAlister VC, Mahalati K, Peltekian KM, Fraser A, MacDonald AS. McAlister VC, et al. Ther Drug Monit. 2002 Jun;24(3):346-50. doi: 10.1097/00007691-200206000-00004. Ther Drug Monit. 2002. PMID: 12021624 Clinical Trial.

7

Kidney transplantation, the Halifax experience.

Belitsky P, MacDonald AS, Lawen J, McAlister V, Bitter-Suermann H, Kiberd B, West K, Sketris I. Belitsky P, et al. Clin Transpl. 1996:231-40. Clin Transpl. 1996. PMID: 9286572

8

Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant.

Bazarah SM, Peltekian KM, McAlister VC, Bitter-Suermann H, MacDonald AS. Bazarah SM, et al. Among authors: mcalister vc. Clin Invest Med. 2004 Aug;27(4):162-7. Clin Invest Med. 2004. PMID: 15453152

9

Modification of xenoantigens on porcine erythrocytes for xenotransfusion.

Doucet J, Gao ZH, MacLaren LA, McAlister VC. Doucet J, et al. Among authors: mcalister vc. Surgery. 2004 Feb;135(2):178-86. doi: 10.1016/j.surg.2003.08.013. Surgery. 2004. PMID: 14739853

10

Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients.

Belitsky P, MacDonald AS, Lawen J, McAlister V, Bitter-Suermann H, Kiberd B. Belitsky P, et al. Transplant Proc. 1997 Nov;29(7A):16S-17S. Transplant Proc. 1997. PMID: 9366920 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters